Emeis Stock Plummets 14% in a Week Ahead of Crucial Results
Emeis stock experienced a sharp decline this Thursday, March 26, trading at 12.34 euros during the session, down 4.19% from the previous day's close. This latest drop is part of a significant downward trend, with the stock losing nearly 14% over the past seven days. The movement comes amid a generally bearish Parisian market, with the CAC 40 down 0.87% during the session.
Emeis' share price is now significantly below its key moving averages. The 50-day moving average, located at 14.17 euros, and the 200-day moving average, at 13.28 euros, are both above the current price, confirming the bearish trend that has been engaged for several weeks. The stock even breached its support level identified at 12.88 euros, corresponding to Wednesday's close, reaching a price zone close to the lower boundary of the Bollinger Bands (12.81 euros). The RSI, at 37, reflects significant selling pressure without yet indicating an extreme oversold situation, the conventional technical threshold being set at 30. The monthly volatility, measured at 17.37%, indicates significant price fluctuations over the recent period. The nearest resistance is at 15.49 euros, which is more than 25% above the current level, illustrating the extent of the path required for a potential technical recovery.
Annual Results 2025 Awaited as a Critical Milestone
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
With the stock having lost nearly 10% over three months, attention is now turning to the upcoming publication of the 2025 annual results, scheduled for April 7. This event will serve as a crucial milestone to assess the operational and financial trajectory of the group specializing in retirement homes and health facilities. The magnitude of the recent decline lends increased importance to this date, as the annual figures will help to gauge any potential progress in terms of recovery. Over the past year, the stock still maintains a positive performance of 18.65%, reflecting the progress made from the depressed levels of early 2025. However, the current correction, concentrated over the last few weeks, significantly erodes these gains. The negative beta of -0.33 also indicates that the stock tends to move out of sync with the market, making its analysis more dependent on its own fundamentals rather than the general trend of the CAC 40. The April 7 publication is thus expected to be the next major catalyst for Emeis' valuation.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
